1. Home
  2. SHFS vs PPBT Comparison

SHFS vs PPBT Comparison

Compare SHFS & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SHF Holdings Inc.

SHFS

SHF Holdings Inc.

N/A

Current Price

$0.44

Market Cap

2.1M

Sector

Finance

ML Signal

N/A

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$1.34

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHFS
PPBT
Founded
2015
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.4M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
SHFS
PPBT
Price
$0.44
$1.34
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 843.0K
41.9K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 95.30
N/A
EPS
N/A
★ N/A
Revenue
★ $7,673,532.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.10
$0.41
52 Week High
$17.76
$5.18

Technical Indicators

Market Signals
Indicator
SHFS
PPBT
Relative Strength Index (RSI) 45.78 34.93
Support Level N/A $1.16
Resistance Level $2.58 $1.60
Average True Range (ATR) 0.24 0.11
MACD -0.36 -0.01
Stochastic Oscillator 0.31 14.81

Price Performance

Historical Comparison
SHFS
PPBT

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The company provides compliance and loan origination services to financial institutions that wish to offer business banking, private banking, and commercial banking services to clients operating in or adjacent to the state-legal cannabis industry. Its core service offerings include: Regulatory compliance consulting and technology, Cannabis-related deposit services and Lending services. The company generates revenue through fee income, investment income, and loan program income.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: